1.Assembled a group of renowned Principal Investigators(PI)in the field of hematology.

2.Possesses extensive clinical research experience in cellular immunotherapy.

3.Owns a Central Reference Laboratory.

4.Owns a Phase I Clinical Trial Center covering nearly 1000 square meters,equipped with negative pressure inhalation drug delivery rooms and wards,an electrocardiogram monitoring center,and isotope wards.

5.Includes clinical research wards for both hematology and oncology.

6.Types of isotope research:

    a.Early clinical trial design based on isotope quantitative pharmacology.

    b.PET receptor imaging technology to evaluate receptor occupancy of new drugs.

    c.Application of stable isotope and radioactive isotope tracing technology in new drug research.